A double-blind, randomized, multicenter study of MP4OX for treatment of perioperative hypotension in patients undergoing primary hip arthroplasty under spinal anesthesia

Anesthesia and Analgesia

Volumn 112, Issue 4, 2011, Pages 759-773

  Van Der Linden, Philippe ^a   Gazdzik, Tadeusz S ^b   Jahoda, David ^c   Heylen, René J ^d   Skowronski, Jan C ^e   Pellar, David ^f   Kofranek, Ivo ^g   Górecki, Andrzej Z ^h   Fagrell, Bengt ⁱ   Keipert, Peter E ^j   Hardiman, Yun J ^k   Levy, Howard ^l  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b Katedra i Oddzial Kliniczny Neurochirurgii   (Poland)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d Campus Sint Jan ^*  (Belgium)

^e Samodzielny Publiczny Szpital Kliniczny AM   (Poland)

^f UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^g Nemocnice Na Bulovce   (Czech Republic)

^h Szpital Kliniczny Dzieciatka Jezus Centrum Leczenia Obrazen w Warszawie   (Poland)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j Oncology   (United States)

^k Biostatistics   (United States)

^l SANGART INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN; HETASTARCH; HYPERTENSIVE AGENT; OXYGENATED POLYETHYLENE GLYCOL MODIFIED HEMOGLOBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; CONSTIPATION; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; FEVER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HIP ARTHROPLASTY; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OLIGURIA; PAIN; PERIOPERATIVE COMPLICATION; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; SUPRAVENTRICULAR PREMATURE BEAT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VOMITING;

EID: 79953193691     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31820c7b5f     Document Type: Article

References (34)

1. Critchley LA, Stuart JC, Short TG, Gin T. Haemodynamic effects of subarachnoid block in elderly patients. Br J Anaesth 1994;73:464-70 (Pubitemid 24307335)
2. Hyderally H. Complications of spinal anesthesia. Mt Sinai J Med 2002;69:55-6 (Pubitemid 34092641)
3. Juelsgaard P, Sand NP, Felsby S, Dalsgaard J, Jakobsen KB, Brink O, Carlsson PS, Thygesen K. Perioperative myocardial ischaemia in patients undergoing surgery for fractured hip randomized to incremental spinal, single-dose spinal or general anaesthesia. Eur J Anaesthesiol 1998;15:656-63 (Pubitemid 29022960)
4. Sural S, Sharma RK, Singhal M, Sharma AP, Kher V, Arora P, Gupta A, Gulati S. Etiology, prognosis, and outcome of postoperative acute renal failure. Ren Fail 2000;22:87-97 (Pubitemid 30130940)
5. Winslow RM. Cell-free oxygen carriers: scientific foundations, linical development, and new directions. Biochim Biophys Acta 2008;1784:1382-6
6. Vandegriff KD, Winslow RM. Hemospan: design principles for a new class of oxygen therapeutic. Artif Organs 2009;33:133-8
7. Young MA, Riddez L, Kjellström BT, Bursell J, Winslow F, Lohman J, Winslow RM. MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med 2005;33:1794-804 (Pubitemid 41153706)
8. Young MA, Lohman J, Malavalli A, Vandegriff KD, Winslow RM. Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch. J Cardiothorac Vasc Anesth 2009;23:339-47
9. 2 therapeutics. Am J Physiol Heart Circ Physiol 2003;285:H1411-9 (Pubitemid 37169493)
10. Olofsson C, Ahl T, Johansson T, Larsson S, Nellgård P, Ponzer S, Fagrell B, Przybelski R, Keipert P, Winslow N, Winslow RM. A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology 2006;105:1153-63 (Pubitemid 44808579)
11. Olofsson C, Nygards EB, Ponzer S, Fagrell B, Przybelski R, Keipert PE, Winslow N, Winslow RM. A randomized, singleblind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus Med 2008;18:28-39 (Pubitemid 351239315)
12. Vandegriff KD, Malavalli A, Mkrtchyan GM, Spann SN, Baker DA, Winslow RM. Sites of modification of Hemospan, a poly(ethylene glycol)-modified human hemoglobin for use as an oxygen therapeutic. Bioconjug Chem 2008;19: 2163-70
13. Ertmer C, Kohler G, Rehberg S, Morelli A, Lange M, Ellger B, Bollen Pinto B, Rubig E, Erren M, Fischer LG, van Aken H, Westphal M. Renal effects of saline-based 10% pentastarch versus 6% tetrastarch infusion in ovine endotoxemic shock. Anesthesiology 2010;112:936-47
14. Riesmeier A, Schellhaass A, Boldt J, Suttner S. Crystalloid/ colloid versus crystalloid intrvascular volume administration before spinal anesthesia in elderly patients: the influence on cardiac output and stroke volume. Anesth Analg 2009; 108:650-4
15. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008;299: 2304-12 (Pubitemid 351724397)
16. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10:R73- 82
17. Frank B, Gottlieb K. Amylase normal, lipase elevated: is it pancreatitis? A case study and review of the literature. Am J Gastroenterol 1999;94:463-9 (Pubitemid 29084670)
18. Viele MK, Weiskopf RB, Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 1997;86:848-58
19. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD. NO scavenging and the hypertensive effect of hemoglobinbased blood substitutes study in opossum. Free Radic Biol Med 2004;36:685-97 (Pubitemid 38264413)
20. Hü ter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009;13:R23-31
21. Boldt J. PRO: hydroxyethylstarch can be safely used in the intensive care patient: the renal debate. Intensive Care Med 2009;35:1331-6
22. Keipert PE, Olofsson C, Winslow RM. Hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA 2008;300:1295-6
23. Silverman TA, Weiskopf RB. Hemoglobin-based oxygen carriers: current status and future directions. Anesthesiology 2009;111:946-63
24. Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood 2006;108:3603-10
25. Drobin D, Kjellstrom BT, Malm E, Malavalli A, Lohman J, Vandegriff KD, Young MA, Winslow RM. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J Appl Physiol 2004;96:1843-53 (Pubitemid 38580011)
26. Young MA, Riddez L, Kjellstrom BT, Winslow RM. Effect of maleimide-polyethylene glycol hemoglobin (MP4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: comparison with crystalloid and blood. J Trauma 2007;63:1234-44
27. Lui FE, Dong P, Kluger R. Polyethylene glycol conjugation enhances the nitrite reductase activity of native and crosslinked hemoglobin. Biochemistry 2008;47:10773-80
28. Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care 2005;9:S1-9 (Pubitemid 43173682)
29. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65 (Pubitemid 43145060)
30. White HD, Simes J, Anderson NE, Hankey GJ, Watson JD, Hunt D, Colquhoun DM, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM. Pravastatin therapy and the risk of stroke. N Engl J Med 2000;343:317-26 (Pubitemid 30616697)
31. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K; ESC Committee for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416 (Pubitemid 40283098)
32. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69
33. Bellomo R, Ronco C, Kellum J, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs-the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12
34. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47